Deletion 17p (del 17p) is a rare genomic aberration found in patients with chronic lymphocytic leukemia (CLL).
The incidence of del 17p varies from 5% to 9% in newly diagnosed patients with CLL while it is up to 50% in patients with relapsed/refractory disease.